| [1] |
Connelly-Smith L, Alquist CR, Aqui NA, et al. Guidelines on the use of therapeutic Apheresis in clinical practice- evidence-based approach from the writing committee of the American Society for Apheresis: The Ninth Special Issue[J]. J Clin Apher, 2023, 38: 77-278.
|
| [2] |
Chen Y, Han T, Duan Z; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Clinical application of artificial liver and blood purification: expert consensus recommendations. Hepatol Int, 2023, 17(1):4-17.
|
| [3] |
Padmanabhan A, Connelly Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: The Eighth Special Issue[J]. J Clin Apher, 2019, 34: 171-354.
|
| [4] |
European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute ((fulminant)) liver failure[J]. J Hepatol, 2017, 66: 1047-1081.
|
| [5] |
Abe T, Matsuo H, Abe R, et al. The Japanese Society for apheresis clinical practice guideline for therapeutic apheresis[J]. Ther Apher Dial, 2021, 25:728-876.
|
| [6] |
Brar HS, Dadlani A, Ng AM, et al. Successful high-volume plasmapheresis in acute liver failure[J]. Cureus, 2021, 13(7): e16143.
|
| [7] |
Mochida S. Acute liver failure and acute-on-chronic liver failure in Japan[J]. Nihon Shokakibyo Gakkai Zasshi, 2020, 117(9):739-749.
|
| [8] |
Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: An open randomized controlled trial[J]. J Hepatol,2016, 64:69-78.
|
| [9] |
Agarwal B, Bañares-Cañizares R, Saliba F, et al. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute on chronic liver failure[J]. J Hepatol, 2023, 79(1):79-92.
|
| [10] |
Ballester MP, Elshabrawi A, Jalan R. Extracorporeal liver support and liver transplantation for acute-on-chronic liver failure[J]. Liver Int,2023.
|
| [11] |
Wang L, Xu W, Zhu S, et al. Double Plasma Molecular Adsorption System with Sequential Low-dose Plasma Exchange in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Prospective Study[J]. J Clin Transl Hepatol, 2023, 11(4):908-917.
|
| [12] |
Wu C, Peng W, Cheng D, et al. Efficacy and economic evaluation of nonbiological artificial liver therapy in acute-on-chronic hepatitis B liver failure[J]. J Clin Transl Hepatol, 2023, 11(2):433-440.
|
| [13] |
Orme JJ, Enninga EAL, Lucien-Matteoni F, et al. Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles[J]. J Immunother Cancer, 2020, 8: e001113.
|
| [14] |
Liu Y, Zheng LH, Xu WX, et al. Efficacy of plasma exchange and a double-plasma molecular absorption system for treating immune checkpoint inhibitor-related hepatitis[J]. Hepat Mon, 2023, e137153.
|
| [15] |
Gan K, Li Z, Bao S, et al. Clinical outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis[J]. Transpl Immunol, 2021, 69:101476.
|
| [16] |
Hakeem AR, Sandeep J. Subramaniam S, et al. Therapeutic plasma exchange for management of early allograft dysfunction after living donor liver transplant: an unmatched cohort study[J]. Exp Clin Transplant, 2021, 19(11):1182-1190.
|
| [17] |
Alam S, Lai BB, Sood V, et al. AARC-ACLF score: best predictor of outcome in children and adolescents with decompensated Wilson disease[J]. Hepatol Int, 2019, 3: 330-338
|
| [18] |
Camarata MA, Gottfried M, Rule JA, et al. Outcomes of acute liver injury in adults due to Wilson's disease: Is survival without transplant possible[J]? Liver Transpl, 2020, 26:330-336.
|
| [19] |
Pawaria A, Sood V, Lal BB, et al. Ninety days transplant free survival with high volume plasma exchange in Wilson disease presenting as acute liver failure[J]. J Clin Apher, 2021, 36: 109-117.
|
| [20] |
Kolovou G, Diakoumakou O, Kolovou V, et al. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia[J]. Eur J Prev Cardiol, 2020, 27:157-165.
|
| [21] |
Ipe TS, Davis AR, Raval JS. Therapeutic plasma exchange in myasthenia gravis: a systematic literature review and mata-analysis of comparative evidence[J]. Front Neurol, 2021, 12:662856.
|
